Watchlist Price Alert

Palvella Therapeutics Inc... (PVLA)

NASDAQ: PVLA · Real-Time Price · USD

25.22

1.73 (7.36%)

At close: Jun 06, 2025, 3:02 PM

Palvella Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-17.43M	18.69M	-27.55M
Depreciation & Amortization	n/a	n/a	n/a
Stock-Based Compensation	830K	603K	427K
Other Working Capital	-453K	-904K	-359K
Other Non-Cash Items	5.96M	-29.85M	10.66M
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	-193K	-3.15M	1.62M
Operating Cash Flow	-10.84M	-13.7M	-14.84M
Capital Expenditures	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a
Debt Repayment	78.43M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	8.65M	5M	34K
Financial Cash Flow	87.09M	5M	9.57M
Net Cash Flow	76.25M	-8.7M	-5.27M
Free Cash Flow	-10.84M	-13.7M	-14.84M